Core Insights - The healthcare sector, particularly pharmaceutical and medical device companies, showed strong performance in the 2025 earnings season, outperforming the industry average [1][2] - Key companies discussed include Eli Lilly, AstraZeneca, Edwards Lifesciences, and Medtronic, highlighting significant revenue growth drivers [1] Sector Performance - The earnings reports reflect a backdrop of challenges such as geopolitical shifts, pricing pressures, and patent losses affecting the industry [2]